Natera Inc (NTRA)

NASDAQ HEALTHCARE
$231.41 +2.19% RSI 62 Neutral Add Alert

Moving Averages

SMA 200
$205.21
Price above

Company Profile

Natera, Inc., a diagnostic company, develops and markets molecular testing services globally. The company is headquartered in San Carlos, California.

Sector
HEALTHCARE
Industry
DIAGNOSTICS & RESEARCH
Market Cap
$31.15B
P/E Ratio
None
EPS
$-1.62
Beta
1.544
Dividend Yield
0.00%
52-Week High
$256.36
52-Week Low
$131.81

Similar stocks in DIAGNOSTICS & RESEARCH

TMO
Thermo Fisher Scientific Inc
RSI 46.0
ILMN
Illumina Inc
RSI 56.0
MTD
Mettler-Toledo International Inc
RSI 48.0
CSTL
Castle Biosciences Inc
RSI 51.0
FONR
Fonar Corp
RSI 75.0
CRL
Charles River Laboratories International Inc
RSI 57.0
BDSX
Biodesix Inc
RSI 62.0
WGS
GeneDx Holdings Corp - Class A
RSI 57.0
DGX
Quest Diagnostics Inc
RSI 36.0
NEO
Neogenomics Inc
RSI 35.0

Data last updated: June 13, 2026 at 12:57 AM EDT

Track NTRA for free

Get e-mail RSI alerts when Natera Inc enters oversold or overbought territory. Free forever.

Add Alert